Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
activateimmunotherapy.com

See what CB Insights has to offer

Investors Count

1

Activate Immunotherapy Funding, Activate Immunotherapy Valuation & Activate Immunotherapy Revenue

2 Fundings

Activate Immunotherapy's latest funding round was a Unattributed for on August 15, 2016.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

8/15/2016

Unattributed

Undisclosed Investors

1

Other Investors

0

Date

8/15/2016

Round

Unattributed

Other Investors

Amount

Investors

Undisclosed Investors

Valuation

Revenue

Sources

1

0

Activate Immunotherapy Investors

1 Investors

Activate Immunotherapy has 1 investors. David Murdock invested in Activate Immunotherapy's Other Investors funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1
Other Investors

Angel Investor (Individual)

First funding

Last Funding

Investor

Rounds

1
Other Investors

Board Seats

Type

Angel Investor (Individual)

Location

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.